Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

A new method creates unique chemical structures that could improve drug discovery.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

The new compound may be a safer alternative to finasteride for prostate protection.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

JAK inhibitors show promise for treating skin diseases effectively and safely.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Biological therapy boosts the immune system to effectively fight melanoma.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

SeV-Tp speeds up healing of drug-resistant infections by targeting wounds and killing bacteria with light activation.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Tofacitinib may help treat hair loss in children with alopecia areata.

Ruxolitinib cream may help treat severe hair loss in children.